NCT02080559View on ClinicalTrials.gov

Investigating the Immune Response to 4CMenB in Infants

PHASE4CompletedINTERVENTIONAL
Enrollment

187

Participants

Timeline

Start Date

July 21, 2014

Primary Completion Date

June 30, 2016

Study Completion Date

April 27, 2018

Conditions
Meningitis
Interventions
BIOLOGICAL

4CMenB

0.5ml IM

Trial Locations (1)

OX3 7LE

Oxford Vaccine Group, Centre for Clininal Vaccinology & Tropical Medicine, Oxford

Sponsors

Collaborators (1)

Novartis Vaccines
All Listed Sponsors
collaborator

Public Health England

OTHER_GOV

collaborator

Imperial College London

OTHER

collaborator

Novartis Vaccines

INDUSTRY

collaborator

European Commission

OTHER

lead

University of Oxford

OTHER

NCT02080559 - Investigating the Immune Response to 4CMenB in Infants | Biotech Hunter | Biotech Hunter